TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hemorrhagic Fever Risk Factors
Research from Karadeniz Technical University, Department of Internal Medicine has provided new information about hemorrhagic fever risk factors
September 9th, 2008
A report, 'Peripheral blood natural killer cells in Crimean-Congo hemorrhagic fever,' is newly published data in Journal of Clinical Virology. "The relationship of changes in the peripheral blood lymphocyte subgroups during Crimean-Congo hemorrhagic fever (CCHF) to prognosis has not been reported. To determine peripheral blood lymphocyte subgroups in CCHF patients at the time of diagnosis and relate these to clinical outcome," scientists in Trabzon, Turkey report. "Peripheral blood samples were obtained from the patients treated at the Karadeniz Technical University Hospital for CCHF in 2004. Lymphocyte subgroups were analyzed by flow cytometry on these samples...
Source: TB & Outbreaks Week (2008-09-09)
|
